Summary
Electron microscopy of cultured P388 leukemia cells revealed morphological differences between the Adriamycin-resistant (P388/ADR) and-sensitive (P388/0) cell lines. P388/ADR cells showed longer villus-like protrusions and large foldings of the plasma cell membrane, whereas P388/0 cells had only short membrane protrusions. Western blot analysis of cells revealed the increased expression of a glycoprotein of 170–180 kDa (P-glycoprotein) in P388/ADR cells as compared with P388/0 cells, which is consistent with the findings of other studies. A modulation of the membrane morphology of in vitro P388/ADR cells was evident from one i.p. in vivo passage for 10 days, by a reversion to the nonruffled sensitive-cell morphology. Long-term P388/ADR culture cells showed a reduction in membrane folding with as little as a 4-h exposure to the peritoneal ascitic fluid obtained when the tumor was harvested. However, there was no alteration in the expression of P-glycoprotein or in the sensitivity to Adriamycin in either of the P388 cell lines an i.p. tumor. Thus, the modulation of membrane morphology was related to the tumor cell environment rather than the abundance of P-glycoprotein in the plasma membrane.
Similar content being viewed by others
References
Bech-Hansen NT, Till JE, Ling V (1976) Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. J Cell Physiol 88: 23
Center MS (1985) Mechanisms regulating cell resistance to Adriamycin: evidence that drug accumulation in resistance cells is modulated by phosphorylation of a plasma membrane glycoprotein. Biochem Pharmacol 34: 1471
Dano K (1973) Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 323: 466
Dano K (1983) Mechanism of resistance to anthracycline and vinca alkaloids. In: Proceedings of the 13th International Cancer Congress, part C, Biology of cancer, vol. 2
Fairbanks G, Steck TL, Wallach DHF (1971) Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10: 2606
Ganapathi R, Reiter W, Krishan A (1982) Intracellular Adriamycin levels and cytotoxicity in Adriamycin-sensitive and Adriamycin-resistant P388 mouse leukemia cells. J Natl Cancer Inst 68: 1027
Inaba M, Kobayashi H, Sakurai Y, Johnson RK (1979) Active efflux of daunorubicin and Adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res 39: 2200
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152
Kartner N, Evernden-Porelle D, Bradley G, Ling V (1985) Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature 316: 820
Kessel D, Corbett T (1985) Correlation between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice. Cancer Lett 28: 187
Kessel D, Botterill V, Wodinsky I (1968) Uptake and retention of daunomycin by mouse leukemia cells as factors in drug response. Cancer Res 28: 938
Kramer RA, Zakher J, Kim G (1988) Role of the glutathione redox cycle in acquired and de novo multidrug resistance. Science 241: 694
Ling V, Kartner N, Sudo T, Siminovitch L, Riordan JR (1983) Multidrug-resistance in Chinese hamster ovary cells. Cancer Treat Rep 67:869
Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346
Radel S, Mayhew E, Hurley E, Zeigel R (1986) Cell surface differences between Adriamycin-resistant and-sensitive P388 leukemia cells. J Cell Biol 103: 338a
Riordan JR, Ling V (1979) Purification of P-glycoprotein from plasma membrane vesicles of Chinese hamster ovary cell mutants with reduced colchicine permeability. J Biol Chem 254: 1051
Schabel FM Jr, Skipper HE, Trader MW, Laster WR Jr, Corbett TH, Griswold DP Jr (1980) Concepts for controlling drug-resistant tumor cells. In: Breast cancer. Experimental and clinical aspects. Pergamon, Oxford, p 199
Skipper HE, Schabel FM, Lloyds HH (1978) Experimental therapeutics and kinetics: selection and overgrowth of specifically and permanently drug-resistant tumor cells. Semin Hematol 15: 207
Skovsgaard T (1978) Mechanisms of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells. Cancer Res 38: 4722
Towbin H, Staehelin T, Gorden J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350
Tsuruo T, Fidler IJ (1981) Differences in drug sensitivity among tumor cells from parental tumors, selected variants and spontaneous metastases. Cancer Res 41: 3058
Vasanthi LG, Bakanauskas VJ, Cogner AD (1986) Early changes accompanying development of Adriamycin resistance in spheroids of a mouse mammary carcinoma line. Anticancer Res 6: 567
Author information
Authors and Affiliations
Additional information
Supported in part by NIH grants CA09072, CA21071, CA24538, CA37304, and CA40553
Rights and permissions
About this article
Cite this article
Radel, S., Fredericks, W., Mayhew, E. et al. P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells. Cancer Chemother. Pharmacol. 25, 241–246 (1990). https://doi.org/10.1007/BF00684879
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00684879